Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: Vertex Pharmaceuticals vs. Incyte

TheMotleyFool

0 0

Better Buy: Vertex Pharmaceuticals vs. IncytePhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

If you picked which stock to buy based solely on year-to-date performance, Incyte (NASDAQ: INCY) would get the nod over Vertex Pharmaceuticals (NASDAQ: VRTX). Both biotech stocks have been winners so far in 2019, but Incyte's shares are up a little over 3% more than Vertex.

But choosing a stock to buy only on historical performance isn't smart. You're much better off focusing on what lies ahead rather than what's in the past. Here's what you need to know about Vertex and Incyte to make a well-informed decision between these two biotech stocks.

Image source: Getty Images.

Source Fool.com

Like: 0

INCY

Share